Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Schrodinger Inc
(NQ:
SDGR
)
19.87
+0.38 (+1.95%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Schrodinger Inc
< Previous
1
2
3
4
5
Next >
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 16, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Presents New Preclinical Data Supporting Advancement of CDC7 Inhibitor Development Candidate, SGR-2921, at American Society of Hematology 2022 Annual Meeting
December 12, 2022
From
Schrödinger
Via
Business Wire
Schrödinger to Present at Piper Sandler 34th Annual Healthcare Conference
November 21, 2022
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
November 18, 2022
From
Schrödinger
Via
Business Wire
Schrödinger to Present at Jefferies 13th Annual London Healthcare Conference
November 07, 2022
From
Schrödinger
Via
Business Wire
Schrödinger Reports Third Quarter 2022 Financial Results
November 03, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger To Present New Preclinical Data From Its CDC7 Inhibitor Program At American Society Of Hematology 2022 Annual Meeting
November 03, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger to Announce Third Quarter 2022 Financial Results on November 3
October 20, 2022
From
Schrödinger
Via
Business Wire
Schrödinger Hosts Platform Day
October 06, 2022
From
Schrödinger
Via
Business Wire
Schrödinger to Host Platform Day on October 6, 2022
September 20, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger to Present at Citi’s 17th Annual BioPharma Conference
August 31, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports Inducement Grants To Newly Appointed Chief Financial Officer
August 18, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Appoints Geoffrey Porges as Chief Financial Officer
August 18, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports Second Quarter 2022 Financial Results
August 04, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger to Announce Second Quarter 2022 Financial Results on August 4
July 21, 2022
From
Schrödinger
Via
Business Wire
Schrödinger Announces FDA Clearance of Investigational New Drug Application for SGR-1505, a MALT1 Inhibitor
June 28, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Convenes Global Educators For Second Annual Educator’s Day
June 22, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger to Present at Jefferies Healthcare Conference
June 02, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Announces Appointment of Arun Oberoi to Board of Directors
May 19, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger to Present at Citi Biotech Virtual Co-Panel Day
May 13, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports First Quarter 2022 Financial Results
May 04, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger to Announce First Quarter 2022 Financial Results on May 4
April 20, 2022
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 19, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports New Preclinical Data Supporting Advancement of Its Wee1 Inhibitor Program at American Association of Cancer Research 2022 Annual Meeting
April 12, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 17, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports Financial Results for the Fourth Quarter and Full Year 2021
February 24, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 17, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger to Announce Fourth Quarter and Full-Year 2021 Financial Results on February 24
February 10, 2022
From
Schrödinger
Via
Business Wire
Schrödinger to Present at SVB Leerink Virtual 11th Annual Global Healthcare Conference
February 08, 2022
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 20, 2022
From
Schrödinger, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.